In contrast, in terms of frequency, the most predominant NKG2A+ KIR− CD57− and NKG2A− KIR− CD57− NK cell subsets harbored very low degranulation against AML cells (Figure 5E). This evidence concerns the gene B3GAT1 and acute myeloid leukemia.